UPC takes strong stance on therapeutic antibody inventions (Sanofi v Amgen, UPC_CFI_1/202)
http://ipkitten.blogspot.com/2024/07/upc-takes-strong-stance-on-therapeutic.html The Central Division of the UPC has issued its first revocation order (Sanofi v Amgen, UPC_CFI_1/202). The decision is not just remarkable for being the first decision of its kind. The UPC Central Division also takes a strong stance on the patentability of therapeutic antibody inventions in Europe. The Central... Continue reading